Maravai LifeSciences Holdings (STU:MAR) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


STU:MAR Maravai LifeSciences Holdings Inc STU:MAR
62 GF Score
Price €5.00
GF Value €3.32
! 8 Warning Signs
View Full Analysis

What is Maravai LifeSciences Holdings Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Maravai LifeSciences Holdings's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

STU:MAR vs ANRO, BBOT, REPL: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Maravai LifeSciences Holdings's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maravai LifeSciences Holdings Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Maravai LifeSciences Holdings's Margin of Safety % (DCF Earnings Based) falls into.


STU:MAR
62GF Score
Maravai LifeSciences Holdings Inc STU:MAR
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Maravai LifeSciences Holdings (STU:MAR) Overvalued in 2026?

Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued. The current stock price of €5.00 is trading 50.6% above its estimated GF Value™ of €3.32.

Key valuation signals for STU:MAR:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €3.32 vs. price of €5.00 (50.6% above fair value)
  • GF Score™: 62/100 with 8 warning signs

No single metric tells the full story. See the STU:MAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maravai LifeSciences Holdings Business Description

Other Exchanges MRVI:USAMAR:Germany
Address 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
62GF Score

Get the complete analysis for STU:MAR

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.00
Price
€3.32
GF Value